Zhonghua Yan

Drug Discovery Laboratory (Norway)

Papers

1

Total Citations

11

H-Index

1

About

Zhonghua Yan is a leading figure in the development of high-throughput biophysical screening technologies, with a primary focus on advancing antibody discovery and therapeutic development. His most cited work, "Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development" (2018, 11 citations), tackles a critical bottleneck in drug discovery: the slow, labor-intensive sample preparation that has traditionally prevented flow cytometry from serving as a primary screening method, despite its superior sensitivity and accuracy. Yan’s key contribution lies in engineering an automated, high-content workflow that dramatically increases throughput, enabling the rapid, precise identification of high-affinity therapeutic antibodies. This innovation directly addresses the growing demand for efficient screening platforms in the era of antibody-based therapeutics. While his citation count reflects a focused, emerging body of work, Yan’s research is notable for its practical, translational impact—bridging the gap between advanced instrumentation and real-world drug development pipelines. His achievements position him as a key innovator in the intersection of automation, cytometry, and biologics discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development
11 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Drug Discovery Laboratory (Norway)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago